CHINA ULCERATIVE COLITIS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Overview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Drug Therapy
• Market Snippet, By Dosage Form
• Market Snippet, By Distribution Channel
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Regulatory Scenario
• PEST Analysis
• Recent Product Launch/Approval
• Epidemiology
• Mergers and Acquisitions

4. China Ulcerative Colitis Market, By Drug Therapy, 2026-2033 (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2026 - 2033
• Segment Trends
• 5-Aminosalicylates
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Mesalazine
• Balsalazide
• Olsazaline
• Others
• Monoclonal Anibodies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Vedolizumab
• Adalimumab
• Infliximab
• Golimumab
• Ustekimab
• Steroids
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Balsalazide
• Prednisone
• Beclomethasone
• Deflazacort
• Others
• Antibiotics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Late Stage Pipeline Drugs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Zeposia (ozanimod)
• Etrasimod
• Others
• Other Drugs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. China Ulcerative Colitis Market, By Dosage Form, 2026 - 2033 (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2026 - 2033
• Segment Trends
• Parenteral
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Oral
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. China Ulcerative Colitis Market, By Distribution Channel, 2026 - 2033 (USD Mn)

• Introduction
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2026 - 2033
• Segment Trends
• Hospital Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Retail Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
• Online Pharmacies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Competitive Landscape

• Company Profiles
• AbbVie Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Johnson & Johnson
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Celltrion Healthcare Co., Ltd.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Takeda Pharmaceutical Company Limited
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Eli Lilly and Company
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• AstraZeneca Plc
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Pfizer Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Bristol-Myers Squibb Company
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Amgen, Inc.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Salix Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Zeria Pharmaceutical Co., Ltd.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• InDex Pharmaceuticals
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Teva Pharmaceutical Industries Ltd.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Boehringer Ingelheim
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• EA Pharma Co., Ltd.
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Theravance Biopharma
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• HUTCHMED
• Company Overview
• Drug Portfolio
• Financial Performance
• Recent Developments/Updates
• Strategies
• Analyst Views

8. Section

• References
• Research Methodology
• About us and Sales Contact